Department of Infectious Diseases, University of Chicago, USA
Opinion
Covid-19 is Prevented in High-risk Individuals by an Antibody Medication Developed by AstraZeneca
Author(s): Michael Smith*
DOI:
10.37421/2576-1420.2021.6.192
Journal of Infectious Diseases and Medicine received 59 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 